| Product NDC: | 44087-8090 |
| Proprietary Name: | Serophene |
| Non Proprietary Name: | clomiPHENE citrate |
| Active Ingredient(s): | 50 mg/1 & nbsp; clomiPHENE citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 44087-8090 |
| Labeler Name: | EMD Serono, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018361 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19820322 |
| Package NDC: | 44087-8090-6 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (44087-8090-6) > 10 TABLET in 1 BLISTER PACK |
| NDC Code | 44087-8090-6 |
| Proprietary Name | Serophene |
| Package Description | 1 BLISTER PACK in 1 CARTON (44087-8090-6) > 10 TABLET in 1 BLISTER PACK |
| Product NDC | 44087-8090 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clomiPHENE citrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19820322 |
| Marketing Category Name | NDA |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | CLOMIPHENE CITRATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |